{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T16:49:40Z","timestamp":1750956580725},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1001\/amajethics.2024.512","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T12:48:47Z","timestamp":1720010927000},"page":"E512-519","source":"Crossref","is-referenced-by-count":2,"title":["How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?"],"prefix":"10.1001","volume":"26","member":"10","published-online":{"date-parts":[[2024,7,1]]},"container-title":["AMA Journal of Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalofethics.ama-assn.org\/article\/how-should-risks-and-benefits-short-acting-opioids-be-evaluated-care-inpatients-oud\/2024-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T12:48:49Z","timestamp":1720010929000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalofethics.ama-assn.org\/article\/how-should-risks-and-benefits-short-acting-opioids-be-evaluated-care-inpatients-oud\/2024-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":0,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,1]]}},"alternative-id":["10.1001\/amajethics.2024.512"],"URL":"https:\/\/doi.org\/10.1001\/amajethics.2024.512","relation":{},"ISSN":["2376-6980"],"issn-type":[{"value":"2376-6980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}